A new set of global clinical guidelines has been released, redefining how obesity is diagnosed. The Lancet Diabetes & Endocrinology Commission, supported by 75 medical organizations worldwide, has introduced two diagnostic categories: clinical obesity and pre-clinical obesity. This approach aims to provide a more precise diagnosis based on individual risk factors rather than relying solely on body mass index (BMI).

Dr. Robert Kushner, an obesity expert from Northwestern Medicine and a member of the commission, stated, "The commission’s report is a major step forward in recognizing obesity as a disease and not merely a risk factor. It also helps clinicians identify individuals who are in need of treatment."

Clinical obesity is now defined as a chronic disease with specific signs of organ dysfunction due to excess body fat. Treatment should focus on improving or regaining reduced body functions. Pre-clinical obesity involves varying health risks without ongoing complications from excess fat, with care aimed at reducing those risks.

The guidelines suggest that all individuals with obesity receive health advice and evidence-based care without stigma. Importantly, clinical obesity should qualify for health insurance coverage independently of other diseases like Type 2 diabetes.

Media can attend the virtual launch of the commission on January 16th from 8 a.m. to noon ET. Dr. Kushner will be available for interviews starting January 20th through Kristin Samuelson at Northwestern University.